-
Type 1 diabetes and automated insulin delivery systems: Meta-analysis proves efficacy
In a study published in eClinicalMedicine, researchers at the German Diabetes Center (DDZ) show that automated insulin delivery (AID) systems... Read more -
Risk groups for type 2 diabetes can also be identified at an older age
A recent study provides evidence that in people without diabetes, six risk groups for cardiometabolic complications previously identified in middle-aged... Read more -
Dual-action approach targeting inflammation shows potential as type 1 diabetes treatment
A study co-led by Indiana University School of Medicine researchers presents a potential new strategy to prevent or slow the... Read more -
Physician-led online nutrition intervention program is successful at improving health for patients with type 2 diabetes
An online physician-led plant-based nutrition intervention program for patients with type 2 diabetes is practical, cost-effective, and successful at improving... Read more -
Experimental drug blocks protein that links low blood sugar to diabetic vision loss
In a new study led by scientists at the Wilmer Eye Institute, Johns Hopkins Medicine researchers say they have determined... Read more -
New review of performance measures for diabetes finds many measures inadequate
A review by the American College of Physicians (ACP) of performance measures for diabetes found that of the 14 performance... Read more -
Cellular quality control linked to insulin resistance in type 2 diabetes
Researchers at Pennington Biomedical Research Center have revealed critical insights into how impaired mitochondrial dynamics and quality control mechanisms in... Read more -
Diabetes medication may increase risk of perioperative ketoacidosis
Sodium-glucose cotransporter-2 inhibitors (SGLT2i), or gliflozins, are medications used in the treatment of type 2 diabetes mellitus (T2DM). They are... Read more -
Many Medicaid enrollees have restricted access to SGLT2 inhibitors, GLP-1 receptor agonists
Many Medicaid enrollees with type 2 diabetes have restricted access to cardioprotective medications, including sodium-glucose cotransporter-2 inhibitors (SGLT2is) and glucagon-like... Read more -
Investigational test detects earliest stages of autoimmune assault that causes type 1 diabetes, scientists report
An investigational blood test for type 1 diabetes can accurately detect the disorder's characteristic autoimmunity with only small samples of... Read more -
New technique protects 'architecture' of insulin-producing islet cells for transplant into type 1 diabetics
Stem cell-derived pancreatic islets are being studied as a rich transplantable source for insulin production, a therapeutic for type 1... Read more -
No needles needed: Wearable glucose monitors could reveal early diabetes warning signs missed by blood tests
The highs and lows of blood glucose aren't just an energy rollercoaster; they could be a key to detecting diabetes... Read more -
Low-income patients with diabetes are more likely to experience insurance instability, researchers find
An Oregon Health & Science University-led study reveals that low-income adults with diabetes are more likely to go in and... Read more -
Study identifies link between body clock disruption and metabolic disease
Northwestern Medicine investigators have discovered how disruptions in the circadian rhythm in our muscles combined with poor diet can contribute... Read more -
Researcher uses virtual reality to help pharmacists improve diabetes care
For many of the almost 40 million people in the U.S. who live with diabetes, monitoring blood sugar levels multiple... Read more
